Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background/Objectives: Isotretinoin has revolutionized the management of acne vulgaris. However, concerns continue regarding the adverse effect profile of isotretinoin. This study aims to review the adverse effects experienced by patients started on isotretinoin by a single dermatologist. Methods: Retrospective chart review of 1743 patients started on isotretinoin for various dermatological conditions over a 6‐year period. Details of the dose of isotretinoin used, concomitant medications, adverse effects and outcome were recorded. Results: One‐fifth (18.5%) of patients reported no adverse effects during the study period. Cheilitis was the most commonly reported adverse effect, affecting 78% of users, followed by eczema and tiredness, seen in 12% each. However, these were clearly dose‐dependent, as the group treated with doses of isotretinoin under 0.25 mg/kg/day only reported cheilitis in 47%, eczema in 7% and tiredness in 5%, compared with 96%, 16% and 18%, respectively, in those treated with more than 0.75 mg/gm/day. Twenty‐four patients (1.4%) stopped isotretinoin because of adverse effects; a further three patients complained of severe adverse effects on at least one occasion, but continued taking the medication. The adverse effect(s) that led to patients stopping isotretinoin were cheilitis (22 patients), mood change (13), tiredness (12), eczema (6) and pregnancy (2). There were no reported instances of suicidal ideation or attempted suicide. Conclusions: Other than the two oral contraceptive failures, there were no serious adverse events recorded during this review period. Isotretinoin is a very effective medication with a low adverse‐effect profile when used at lower doses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The treatment of severe cystic acne with 13-cis-retinoic acid
Farrell, L. N., Strauss, J. S., & Stranieri, A. M. (1980) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(80)80074-0 · Cited by 194 · cited 1×
“Isotretinoin (13-cis-retinoic acid) revolutionized the management of acne vulgaris and various other skin disorders when it was introduced in the 1980s.(1,2) Isotretinoin was the first medication to modify the disease, rather than provide symptom control.”
BackgroundLow-dose isotretinoin in the treatment of acne vulgaris
Amichai, B., Shemer, A., & Grunwald, M. H. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.11.1061 · Cited by 177
Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review
Marqueling, A. L., & Zane, L. T. (2005) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2005.04.003 · Cited by 166 · cited 2×
“There is extensive literature and ongoing debate regards the possible association between mood change, depression and suicidality, and the use of isotretinoin.(8,9) To date, the majority of case–control and other epidemiological studies”
BackgroundEpidemiology of isotretinoin exposure during pregnancy
Dai, W. S., LaBraico, J. M., & Stern, R. S. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70088-w · Cited by 133 · cited 1×
“Teratogenicity is arguably the most significant, with estimates of 40% of exposed pregnancies associated with significant birth defects.(14) Both cases of pregnancy in this study had been prescribed oral contraceptives, and were considered oral contraceptive failures.”
BackgroundBernstein, C. N., Nugent, Z., Longobardi, T., & Blanchard, J. F. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.417 · Cited by 118
Cited by
Williams, H. C., Dellavalle, R. P., & Garner, S. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60321-8 · Cited by 1,126
Management of Acne Vulgaris: A Review
Eichenfield, D. Z., Sprague, J., & Eichenfield, L. F. (2021) · JAMA · doi:10.1001/jama.2021.17633 · Cited by 389
Rademaker, M., Wishart, J. M., & Birchall, N. M. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12170 · Cited by 58
Self-citationLiang, L., Qi, X., Jiang, X., Chen, T., & Dong, L. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1340068 · Cited by 19
Metadata
- Authors
- Rademaker, M.
- Venue
- Australasian Journal of Dermatology
- Publisher
- Wiley
- Published
- 2010-11
- Volume
- 51
- Issue
- 4
- Pages
- 248-253
- ISSN
- 0004-8380 (ISSN-L)
- 1440-0960
- OpenAlex
- W2109592716
- Cited by
- 162
- References
- 5
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. https://app.cochat.ai/papers/10.1111/j.1440-0960.2010.00657.x
- The paper
- Rademaker, M. (2010). Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australasian Journal of Dermatology. https://doi.org/10.1111/j.1440-0960.2010.00657.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.